NCT03604198 2026-02-19
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
Corcept Therapeutics
Sparrow Pharmaceuticals
Corcept Therapeutics
National Institutes of Health Clinical Center (CC)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia